The NEXT project has successfully engineered a new approach to pancreatic islet transplantation using biomimetic nanomaterials, providing hope to type-1 diabetes patients across the world.
The perspective of lifetime drug administration or insulin infusion is, to say the least, demoralising. And it gets worse for those diabetic patients who don’t respond to insulin administration or don’t experience symptoms of hypoglycemia: They are left with either organ or cadaveric pancreatic islet transplantation options, both suffering from a shortage of donors and limited lifespan.
Further details: New biomaterials enable the engineering of pancreatic islets from single cells